Asensus Surgical (NYSEAMERICAN:ASXC) Stock Price Up 3.3%

Asensus Surgical, Inc. (NYSEAMERICAN:ASXC) shares traded up 3.3% during trading on Friday . The company traded as high as $0.25 and last traded at $0.25. 605,332 shares traded hands during mid-day trading, a decline of 60% from the average session volume of 1,528,514 shares. The stock had previously closed at $0.24.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright downgraded Asensus Surgical from a “buy” rating to a “neutral” rating and cut their price target for the stock from $2.00 to $0.35 in a research note on Thursday, April 4th.

Asensus Surgical Stock Up 3.3 %

The stock has a market capitalization of $67.73 million, a PE ratio of -0.78 and a beta of 1.43.

Asensus Surgical (NYSEAMERICAN:ASXC) last issued its earnings results on Thursday, March 21st. The company reported ($0.07) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by ($0.02). The firm had revenue of $5.43 million during the quarter. Asensus Surgical had a negative return on equity of 135.94% and a negative net margin of 914.46%. As a group, analysts predict that Asensus Surgical, Inc. will post -0.19 earnings per share for the current year.

Institutional Trading of Asensus Surgical

A hedge fund recently raised its stake in Asensus Surgical stock. Avantax Planning Partners Inc. lifted its stake in Asensus Surgical, Inc. (NYSEAMERICAN:ASXC) by 773.0% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 112,936 shares of the company’s stock after acquiring an additional 100,000 shares during the quarter. Avantax Planning Partners Inc.’s holdings in Asensus Surgical were worth $30,000 as of its most recent filing with the Securities & Exchange Commission. 9.35% of the stock is currently owned by institutional investors and hedge funds.

About Asensus Surgical

Asensus Surgical, Inc, a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, the Middle East, Africa, and Asia. It digitizes the interface between the surgeon and the patient to perform performance-guided surgery for surgeons to deliver outcomes to patients.